Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia

Zahari Z 1 , Teh LK , Ismail R , Razali SM

Affiliations 

  • 1 Pharmacogenetics Research Group, Institute for Research in Molecular Medicine Hospital USM, Kelantan, Malaysia
Psychiatr Genet, 2011 Aug;21(4):183-9.
PMID: 21206399 DOI: 10.1097/YPG.0b013e3283437250

Abstract

Variations in the gene for dopamine D2 receptor (DRD2) might have an influence on the outcome of antipsychotic treatment in schizophrenia. The objective of this study was to investigate the influence of DRD2 polymorphisms on treatment outcomes in patients with schizophrenia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications